Previous research demonstrated that NR1H4 exerts neuroprotective effects in Parkinson’s disease by suppressing astrocyte activation and neuroinflammation via the CEBPβ/NF-κB pathway [48]. The gene discussed is CEBPB; the disease is Parkinson disease.